SOS! Defibrotide to the rescue.
Lazarus
Hillard M
HM
Case Western Reserve University, USA.
McCrae
Keith R
KR
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002417:Cattle; D002461:Cell Line, Transformed; D003315:Cornea / Q000378:metabolism / Q000473:pathology; D042783:Endothelial Cells / Q000378:metabolism* / Q000473:pathology; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D006504:Hepatic Veno-Occlusive Disease / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D009102:Multiple Organ Failure / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011089:Polydeoxyribonucleotides / Q000494:pharmacology* / Q000627:therapeutic use; D011485:Protein Binding / Q000187:drug effects; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2; C036901:defibrotide; C496365:FGFR3 protein, human; D051498:Receptor, Fibroblast Growth Factor, Type 3